PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia
SHM Pang, M Minnich, P Gangatirkar, Z Zheng, A Ebert, G Song, RA Dickins, LM Corcoran, CG Mullighan, M Busslinger, ND Huntington, SL Nutt, S Carotta
Leukemia | NATURE PUBLISHING GROUP | Published : 2016
Awarded by National Health and Medical Research Council (NHRMC) of Australia
Awarded by ERC Advanced Grant
Awarded by NATIONAL CANCER INSTITUTE
We thank M Reth and T Mak for mice, J Leahy for animal husbandry and the institute flow cytometry facility for excellent technical assistance. We thank Markus Jaritz for bioinformatic analysis. This work was supported by program and project grants (APP1054925 to SLN and 637345 to SC) and fellowships (APP1058238 to SLN) from the National Health and Medical Research Council (NHRMC) of Australia. SHMP was supported by the Leukaemia Foundation of Australia and SC by an NHMRC Career Development Fellowship. Research of the Busslinger group was supported by Boehringer Ingelheim and an ERC Advanced Grant (291740-LymphoControl). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS.